Terms: = Lung cancer AND SRSF2, Q01130, 6427, SFRS2 AND Treatment
4 results:
1. Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.
Versluis J; Saber W; Tsai HK; Gibson CJ; Dillon LW; Mishra A; McGuirk J; Maziarz RT; Westervelt P; Hegde P; Mukherjee D; Martens MJ; Logan B; Horowitz M; Hourigan CS; Nakamura R; Cutler C; Lindsley RC;
J Clin Oncol; 2023 Oct; 41(28):4497-4510. PubMed ID: 37607457
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of Carboplatin With Cisplatin in Small Cell lung cancer in US Veterans.
Azar I; Yazdanpanah O; Jang H; Austin A; Kim S; Chi J; Alkassis S; Saha BK; Chopra A; Neu K; Mehdi S; Mamdani H
JAMA Netw Open; 2022 Oct; 5(10):e2237699. PubMed ID: 36264573
[TBL] [Abstract] [Full Text] [Related]
3. A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies.
Pesson M; Eymin B; De La Grange P; Simon B; Corcos L
Mol Cancer; 2014 Jan; 13():9. PubMed ID: 24428911
[TBL] [Abstract] [Full Text] [Related]
4. srsf2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines.
Edmond V; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2011 Jun; 10(12):1968-77. PubMed ID: 21555914
[TBL] [Abstract] [Full Text] [Related]
